HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 17.58

Change

-0.93 (-5.02)%

Market Cap

USD 4.37B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

N/A

USD 161.33B
KMB Kimberly-Clark Corporation

N/A

USD 48.72B
CHD Church & Dwight Company Inc

N/A

USD 24.94B
CLX The Clorox Company

N/A

USD 19.61B
ELF ELF Beauty Inc

N/A

USD 8.45B
COTY Coty Inc

N/A

USD 8.19B
SPB Spectrum Brands Holdings Inc

N/A

USD 2.64B
EPC Edgewell Personal Care Co

N/A

USD 1.98B
PZC PIMCO California Municipal Inc..

N/A

USD 0.63B
YSG Yatsen Holding

N/A

USD 0.32B

ETFs Containing HIMS

EDOC:AU BetaShares Digital Health.. 6.10 % 0.00 %

N/A

N/A
DDOC:XETRA Global X Telemedicine & D.. 4.45 % 0.00 %

N/A

USD 5.39M
DDOC:F Global X Telemedicine & D.. 4.45 % 0.00 %

N/A

USD 4.62M
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

N/A

N/A
IBUY Amplify Online Retail ETF 2.70 % 0.65 %

N/A

USD 0.15B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.14B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

USD 0.14B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 97.53% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.53% 100% F 99% N/A
Trailing 12 Months  
Capital Gain 115.71% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.71% 94% A 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 18.62% 78% C+ 82% B
Dividend Return 18.62% 78% C+ 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.21% 11% F 13% F
Risk Adjusted Return 30.42% 56% F 50% F
Market Capitalization 4.37B 54% F 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.